Skip to contentL
Lifecore Biomedical, Inc.
L
LFCRLifecore Biomedical, Inc. Q4 2015 · 10-K
Revenue$134.45M$134.45M+11.2% vs Q4 2014 Net Income$4.20M$4.20M−7.6% vs Q4 2014 EPS Diluted$0.15$0.15−11.8% vs Q4 2014 Gross Profit$18,668,000+15.6% Free Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Lifecore Biomedical, Inc. · CIK 1005286 · Engraved from SEC EDGAR
derived
Margins · derivedGross margin13.9%+0.5 pt vs Q4 2014
Net margin3.1%−0.6 pt vs Q4 2014
ended May 31, 2015 · filed Jul 31, 2015 · 61 d after period end